— Know what they know.
Not Investment Advice
Also trades as: CHM.AX (ASX) · $vol 0M

CHMMF OTC

Chimeric Therapeutics Limited
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: +0.0%
$0.10
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $4.1M mcap · 26M float · 0.079% daily turnover

Balance Sheet Trends

Total Assets
$1M -94.1% ▼
5Y CAGR: -48.9%
Total Liabilities
$9M -54.1% ▼
5Y CAGR: -4.6%
Shareholders Equity
-$8M -490.6% ▼
Cash & Investments
$799K -86.1% ▼
5Y CAGR: -48.7%
Total Debt
$679K +0.0% ▲
Net Debt
-$120K +97.9% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2022FY2023FY2024FY2025FY2026
— Assets —
Cash$18M$2M$3M$6M$799K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$18M$2M$3M$6M$799K
Net Receivables$41K$7M$87K$5M$29K
Inventory$0$0$0$0$0
Other Current Assets$3M$331K$83K$218K$195K
Total Current Assets$21M$9M$3M$11M$1M
Property, Plant & Equip.$16K$6K$685$0$0
Goodwill & Intangibles$14M$13M$12M$11M$254K
Long-Term Investments$40K$40K$40K$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$14M$13M$12M$11M$254K
Total Assets$35M$22M$15M$22M$1M
— Liabilities —
Accounts Payable$5M$7M$3M$7M$5M
Short-Term Debt$0$0$4M$0$679K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$3M$4M$4M$4M$3M
Total Current Liabilities$9M$15M$14M$15M$9M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$153K$2M$3M$5M$113K
Total Non-Current Liabilities$153K$2M$3M$5M$113K
Total Liabilities$9M$17M$13M$20M$9M
— Equity —
Common Stock$52M$54M$64M$70M$80M
Retained Earnings-$31M-$57M-$67M-$76M-$94M
Accumulated OCI$5M$9M$6M$8M$6M
Total Stockholders Equity$26M$6M$2M$2M-$8M
Total Liabilities & Equity$35M$22M$15M$22M$1M
— Key Metrics —
Total Debt$0$0$4M$0$679K
Net Debt-$18M-$2M$541K-$6M-$120K
Total Investments$40K$40K$40K$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms